Welcome to Trends-in-Medicine, offering independent, cutting-edge articles and information on drugs and devices in development. Our subscribers have access to news and analysis on the latest data, regulatory issues, and trends of interest to the healthcare community.

Covid Update -- May 2022

More than 6 million people have died worldwide, and nearly a million of those have been in the U.S. Here is the latest news of interest on regulatory actions, Covid-19 side effects, testing, treatment, vaccines, and variants – plus answers to a number of questions about Covid-19 vaccines, testing, and treatment from a panel of experts arranged by the International Antiviral Society-USA (IAS-USA).

Covid-19 Update

Here is the latest news of interest on regulatory actions, Covid-19 side effects, testing, treatment, vaccines, and variants – plus some thoughts from the chief executive officers of three pharmas – Lilly, Pfizer, and Roche – from a press conference organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

ROS1 Inhibitors for NSCLC

ROS1-positive non-small cell lung cancer accounts for only a small percentage of NSCLC cases, but there are currently two therapies. Here is a discussion of why more patients aren’t identified, why more don’t get the existing drugs, what happens when a patient progresses on one of these, and what new therapies are on the horizon.

ACC 2022 Preview

Here are some of the impactful trials expected to be presented at the American College of Cardiology meeting April 2-4, 2022, relating to drugs or devices.

Covid-19 Update

Here is the latest Covid-19 news, from the numbers to masks, testing, treatment, and vaccines.

ASCO-GU News

The key news at the meeting was in prostate cancer -- particularly PARP inhibitors but also an androgen receptor inhibitor that may change practice right away and an androgen receptor degrader that holds promise.

CDC on Covid-19 and Pregnancy

A new report by the Centers for Disease Control and Prevention (CDC) found that vaccinating pregnant women with an mRNA vaccine prevents Covid-19 hospitalizations in infants younger than 6 months.